| Literature DB >> 25816068 |
Mansoor Tariq1, Rong Chen2, Hongyu Yuan2, Yanjie Liu2, Yanan Wu2, Junya Wang2, Chun Xia3.
Abstract
BACKGROUND: The Chinese goose is one of the most economically important poultry birds and is a natural reservoir for many avian viruses. However, the nature and regulation of the innate and adaptive immune systems of this waterfowl species are not completely understood due to limited information on the goose genome. Recently, transcriptome sequencing technology was applied in the genomic studies focused on novel gene discovery. Thus, this study described the transcriptome of the goose peripheral blood lymphocytes to identify immunity relevant genes. PRINCIPALEntities:
Mesh:
Substances:
Year: 2015 PMID: 25816068 PMCID: PMC4376690 DOI: 10.1371/journal.pone.0121015
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the cDNA library of goose peripheral blood lymphocytes.
| Category | Before trimmingRaw Data | After trimmingClean data | After assemblyUnigenes |
|---|---|---|---|
|
| 91.93 × 106 | 69.36 × 106 | |
|
| 9.19 | 6.50 | |
|
| 93.65 | ||
|
| 75.45 | ||
|
| 47 | ||
|
| 211,198 | ||
|
| 61,112 | ||
|
| 29,716 | ||
|
| 1,298 | ||
|
| 260 | ||
|
| 18,992 | ||
|
| 201 | ||
|
| 687.87 | ||
|
| 69.5 | ||
Fig 1De novo transcriptome assembly of goose peripheral blood lymphocytes statistical analysis.
A. Length distribution of the assembled all unigenes in the sequenced cDNA library, B. Distribution of the unigenes in RPKM values, and Characteristics of homology search of assembled unigenes against the Nr database; (C) Top 5 species distribution, (D) E-value distribution, (E) Identity distribution, (F) Score distribution.
List of annotations against public databases.
| Annotation database | Number of annotated unigenes | Percentage of annotated unigenes |
|---|---|---|
|
| 211198 | |
|
| 36854 | 17.44% |
|
| 31978 | 15.14% |
|
| 37394 | 17.70% |
|
| 17981 | 8.51% |
|
| 32498 | 15.38% |
|
| 15334 | 7.26% |
|
| 39,585 | 18.74% |
Fig 2Histogram presentation of eukaryotic cluster of orthologous groups (KOG) classification.
A total of 15,334 sequences were annotated into 25 KOG categories.
Fig 3Histogram of Gene Ontology (GO) Classification.
The terms were summarized in three main categories (biological process, cellular component and molecular function) and 67 sub-categories. Right y-axis, percentage of unigenes; Left y-axis, number of unigenes.
Classification of KEGG pathway unigenes from the cDNA library of Goose peripheral blood lymphocytes.
| KEGG Category | Number of Unigenes | Percentage ofUnigenes | Number of KEGG pathways |
|---|---|---|---|
|
|
| ||
| Amino acid metabolism | 742 | 12 | |
| Biosynthesis of other secondary metabolites | 91 | 11 | |
| Carbohydrate metabolism | 1004 | 14 | |
| Energy metabolism | 516 | 9 | |
| Glycan biosynthesis and metabolism | 767 | 14 | |
| Lipid metabolism | 960 | 15 | |
| Metabolism of cofactors and vitamins | 345 | 12 | |
| Metabolism of other amino acids | 321 | 9 | |
| Metabolism of terpenoids and polyketides | 55 | 8 | |
| Nucleotide metabolism | 624 | 2 | |
| Xenobiotics biodegradation and metabolism | 336 | 17 | |
|
|
| ||
| Folding, Sorting and Degeneration | 936 | 7 | |
| Replication and repair | 595 | 7 | |
| Transcription | 386 | 3 | |
| Translation | 917 | 5 | |
|
|
| ||
| Membrane transport | 155 | 2 | |
| Signal transduction | 3145 | 15 | |
| Signaling molecules and interaction | 1334 | 4 | |
|
|
| ||
| Cell communication | 2205 | 7 | |
| Cell growth and death | 1140 | 7 | |
| Cell motility | 493 | 1 | |
| Transport and catabolism | 1448 | 6 | |
|
|
| ||
| Circulatory system | 1032 | 4 | |
| Development | 663 | 3 | |
| Digestive system | 1372 | 9 | |
| Endocrine system | 1277 | 6 | |
| Environmental adaptation | 137 | 4 | |
| Excretory system | 409 | 5 | |
| Immune system | 2757 | 17 | |
| Nervous system | 1816 | 8 | |
| Sensory system | 345 | 5 | |
|
|
| ||
| Cancers | 3871 | 17 | |
| Cardiovascular diseases | 1325 | 5 | |
| Endocrine and metabolic diseases | 217 | 3 | |
| Immune diseases | 337 | 7 | |
| Infectious diseases | 4449 | 22 | |
| Neurodegenerative diseases | 1063 | 5 |
Fig 4Distribution of unigenes involved in the immune system pathways.
A total of 2757 unigenes were involved in the immune system.
Comparison of immune relevant genes of goose with duck, chicken, turkey and zebra finch.
| Unigenes | Gene Symbol | Gene description | Duck | Chicken | Turkey | Zebra finch |
|---|---|---|---|---|---|---|
|
| ||||||
|
| MHCI | Major histocompatibility complex, class I | Present | Present | Present | Present |
|
| MHCII | Major histocompatibility complex, class II | Present | Present | Present | Present |
|
| β2m | Beta-2-microglobulin | Present | Present | Present | Present |
|
| TAPBP | TAP binding protein (tapasin) | Absent | Present | Absent | Absent |
|
| HSP90A | Heat shock protein 90KDa alpha | Present | Present | Absent | Present |
|
| HSP70 | Heat shock protein 70 | Present | Present | Absent | Present |
|
| CTSS | Cathepsin S | Present | Present | Present | Present |
|
| CD8b | T-cell surface glycoprotein CD8 beta | Present | Present | Present | Present |
|
| CD74 | MHC II invariant chain CD74 protein | Present | Present | Present | Present |
|
| RFX5 | Regulatory factor X 5 (influence on HLA II expression) | Present | Present | Absent | Present |
|
| ||||||
|
| TLR2 | Toll-like receptor 2 | Present | Present | Present | Present |
|
| TLR3 | Toll-like receptor 3 | Present | Present | Absent | Present |
|
| TLR4 | Toll-like receptor 4 | Present | Present | Present | Present |
|
| TLR5 | Toll-like receptor 5 | Present | Present | Present | Present |
|
| TLR7 | Toll-like receptor 7 | Present | Present | Present | Present |
|
| TLR13 | Toll-like receptor 13 | Absent | Present | Absent | Absent |
|
| TLR15 | Toll-like receptor 15 | Present | Present | Absent | Absent |
|
| TLR18 | Toll-like receptor 18 | Absent | Absent | Absent | Absent |
|
| TICAM1 | Toll-like receptor adapter molecule 1 | Present | Absent | Absent | Absent |
|
| FADD | FAS-associated death domain protein | Present | Present | Present | Present |
|
| LY75 | Lymphocyte antigen 75 | Present | Present | Present | Present |
|
| LY96 | Lymphocyte antigen 96 | Present | Present | Absent | Present |
|
| MYD88 | Myeloid differentiation primary response protein MyD88 | Present | Present | Present | Present |
|
| ||||||
|
| CCL4 | C-C motif chemokine 4 | Present | Present | Present | Present |
|
| CCL14 | C-C motif chemokine 14 | Present | Absent | Absent | Absent |
|
| CCL19 | C-C motif chemokine 19 | Present | Present | Present | Absent |
|
| CCL20 | C-C motif chemokine 20 | Present | Present | Present | Present |
|
| CCL26 | C-C motif chemokine 26 | Absent | Absent | Present | Absent |
|
| CCR7 | C-C chemokine receptor 7 | Present | Present | Absent | Present |
|
| CCR8 | C-C chemokine receptor 8 | Present | Present | Present | Present |
|
| CCR9 | C-C chemokine receptor 9 | Present | Present | Absent | Present |
|
| CXCR4 | CXC chemokine receptor 4 | Present | Present | Present | Present |
|
| CXCR7 | CXC chemokine receptor 7 | Present | Present | Absent | Present |
|
| CX3CR1 | CX3C chemokine receptor 1 | Present | Present | Absent | Present |
|
| XCR1 | XC chemokine receptor 1 | Present | Present | Absent | Present |
|
| NOX1 | NADPH oxidase | Present | Present | Present | Present |
|
| ||||||
|
| IL1B | Interleukin 1 beta | Absent | Present | Present | Present |
|
| IL6 | Interleukin 6 | Present | Present | Present | Present |
|
| IL8 | Interleukin 8 | Absent | Present | Present | Present |
|
| IL16 | Interleukin 16 | Present | Present | Present | Present |
|
| IL17 | Interleukin 17 | Present | Present | Present | Present |
|
| IL18 | Interleukin 18 | Present | Present | Present | Present |
|
| IL1R1 | Interleukin 1 receptor type 1 | Present | Present | Present | Present |
|
| IL1R2 | Interleukin 1 receptor type 2 | Present | Present | Present | Present |
|
| IL2RA | Interleukin 2 receptor alpha | Absent | Present | Absent | Absent |
|
| IL2RB | Interleukin 2 receptor beta | Present | Present | Absent | Present |
|
| IL2RG | Interleukin 2 receptor gamma | Present | Present | Absent | Present |
|
| IL4R | Interleukin 4 receptor | Present | Present | Present | Present |
|
| IL5RA | Interleukin 5 receptor alpha | Present | Present | Absent | Present |
|
| IL9R | Interleukin-9 receptor | Absent | Present | Absent | Absent |
|
| IL10RA | Interleukin 10 receptor alpha | Present | Present | Present | Present |
|
| IL10R2 | Interleukin 10 receptor 2 | Present | Present | Present | Present |
|
| IL11RA | Interleukin 11 receptor alpha | Present | Present | Present | Present |
|
| IL12RB2 | Interleukin 12 receptor beta-2 | Present | Present | Present | Absent |
|
| IL13RA1 | Interleukin 13 receptor alpha-1 | Present | Present | Absent | Absent |
|
| IL13RA2 | Interleukin 13 receptor alpha-2 | Present | Present | Present | Present |
|
| IL15RA | Interleukin 15 receptor alpha | Absent | Present | Absent | Absent |
|
| IL20RA | Interleukin 20 receptor alpha | Present | Present | Present | Present |
|
| IL21R | Interleukin 21 receptor | Present | Present | Present | Present |
|
| IL23R | Interleukin 23 receptor | Present | Present | Absent | Absent |
|
| IL27B | Interleukin 27 subunit beta | Absent | Absent | Absent | Absent |
|
| IL28RA | Interleukin 28 receptor subunit alpha | Absent | Present | Absent | Absent |
|
| IL31RA | Interleukin 31 receptor subunit alpha | Present | Present | Absent | Absent |
|
| IRAK2 | Interleukin-1 receptor-associated kinase 2 | Present | Present | Present | Present |
|
| BMP2 | Bone morphogenetic protein 2 | Present | Present | Present | Present |
|
| TGFBR2 | TGF-beta receptor-2 | Present | Present | Present | Present |
|
| ||||||
|
| IFNGR1 | Interferon gamma receptor 1 | Present | Present | Present | Present |
|
| IRF1 | Interferon regulatory factor 1 | Present | Present | Present | Present |
|
| IRF2 | Interferon regulatory factor 2 | Present | Present | Present | Present |
|
| IRF3 | Interferon regulatory factor 3 | Absent | Absent | Present | Present |
|
| IRF4 | Interferon regulatory factor 4 | Present | Present | Present | Present |
|
| IRF5 | Interferon regulatory factor 5 | Present | Present | Present | Present |
|
| IRF6 | Interferon regulatory factor 6 | Present | Present | Present | Present |
|
| IRF7 | Interferon regulatory factor 7 | Absent | Present | Absent | Absent |
|
| IRF8 | Interferon regulatory factor 8 | Present | Present | Present | Present |
|
| IRF9 | Interferon regulatory factor 9 | Absent | Absent | Absent | Absent |
|
| IRF10 | Interferon regulatory factor 10 | Absent | Present | Absent | Absent |
|
| MX | Interferon-induced GTP-bindingprotein Mx | Present | Present | Present | Present |
|
| BLNK | B-cell linker protein | Present | Present | Absent | Present |
|
| NOD1 | Nucleotide-binding oligomerization domain-containing protein 1 | Present | Present | Present | Present |
|
| OAS | 2'-5'-oligoadenylate synthetase | Present | Present | Absent | Absent |
|
| ||||||
|
| C2 | Complement C2 | Absent | Present | Absent | Absent |
|
| C4 | Complement C4 | Present | Present | Present | Present |
|
| C4–1 | Complement C4–1 | Absent | Absent | Absent | Absent |
|
| C5 | Complement C5 | Present | Present | Present | Present |
|
| C3 | Complement component 3 | Present | Present | Present | Present |
|
| C4BPA | Complement component 4 binding protein, alpha | Absent | Present | Absent | Absent |
|
| C7 | Complement component C7 | Absent | Absent | Absent | Absent |
|
| C8B | Complement component 8 beta | Absent | Absent | Absent | Absent |
|
| C8G | Complement component C8 gamma chain | Present | Present | Absent | Present |
|
| C1R | Complement component 1, r subcomponent | Present | Present | Present | Present |
|
| C1S | Complement component 1, s subcomponent | Present | Present | Present | Present |
|
| C1qA | Complement C1q subcomponent subunit A | Present | Present | Present | Present |
|
| C1qB | Complement C1q subcomponent subunit B | Present | Present | Present | Present |
|
| C1qC | Complement C1q subcomponent subunit C | Present | Present | Present | Present |
|
| CFI | Complement factor I | Present | Present | Present | Present |
|
| MBL | Mannose-binding lectin | Present | Present | Absent | Absent |
|
| A2M | alpha-2-macroglobulin | Present | Present | Present | Present |
|
| KNG1 | Kininogen-1 | Present | Present | Absent | Present |
|
| ||||||
|
| PRF1 | Perforin-1 | Absent | Present | Absent | Absent |
|
| NFATC. NFAT | Nuclear factor of activated T-cells. cytoplasmic | Present | Present | Present | Present |
|
| MAP3K14 | Mitogen-activated protein kinase 14 | Present | Present | Present | Present |
|
| LCK | Lymphocyte-specific protein tyrosine kinase | Absent | Present | Absent | Absent |
|
| PAK1 | p21-activated kinase 1 | Present | Present | Present | Present |
|
| ZAP70 | Zeta-chain (TCR) associated protein kinase | Present | Present | Present | Present |
|
| LCP2 | Lymphocyte cytosolic protein 2 | Present | Present | Present | Present |
|
| MST1R | Macrophage stimulating 1 receptor | Present | Present | Present | Present |
|
| PTPN1 | Protein tyrosine phosphatase, non-receptor type 1 | Present | Present | Present | Present |
|
| PTPN11 | Protein tyrosine phosphatase, non-receptor type 11 | Present | Present | Present | Present |
|
| CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | Present | Present | Present | Present |
|
| ||||||
|
| NFKBIB | NF-kappa-B inhibitor beta | Absent | Present | Absent | Present |
|
| NFKBIE | NF-kappa-B inhibitor epsilon | Present | Present | Present | Present |
|
| CARD11 | Caspase recruitment domain-containing protein 11 | Present | Present | Present | Present |
|
| BTK | Bruton agammaglobulinemia tyrosine kinase | Present | Present | Present | Present |
|
| MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Present | Present | Present | Present |
|
| NFKB | Nuclear factor NF-kappa-B | Present | Present | Present | Absent |
|
| TRAF3 | TNF receptor-associated factor 3 | Present | Present | Present | Present |
|
| BAFF | B-Cell activating factor | Present | Present | Absent | Absent |
|
| VCAM1 | Vascular cell adhesion molecule 1 | Present | Present | Absent | Present |
|
| TNFAIP3 | Tumor necrosis factor, alpha-induced protein 3 | Present | Present | Present | Present |
|
| ||||||
|
| SOCS1 | Suppressor of cytokine signaling 1 | Present | Present | Present | Present |
|
| SOCS3 | Suppressor of cytokine signaling 3 | Present | Present | Present | Present |
|
| CBL | E3 ubiquitin-protein ligase CBL | Present | Present | Present | Present |
|
| STAT1 | Signal transducer and activator of transcription 1 | Present | Present | Present | Present |
|
| STAT3 | Signal transducer and activator of transcription 3 | Present | Present | Present | Present |
Gene symbols with mark * are already identified in goose species.
Fig 5Comparison of goose immune relevant genes with duck, chicken, turkey and zebra finch.
The number of immune relevant genes of goose and its comparison among the known sequences of duck, chicken, turkey and zebra finch deposited in the NCBI database. (a) represents the total number of immune relevant genes found in the goose, (b-e) represents the immune relevant genes found in duck, chicken, turkey, and zebra finch, and (f-i) represents the immune relevant genes not found in the duck, chicken, turkey, and zebra finch.
Fig 6Amino acid alignment of complement C1q subcomponent subunit A (C1qA).
Amino acid alignment of C1qA shows, signal peptide, collagen like domain and C1q domain are respectively indicated with a bottle green arrow, orange arrow and blue arrow. Blue Triangle indicates the key residues for CRP interaction. Purple Triangle indicates the key residues for IgG interaction. Magenta pentacle indicates the sites for calcium binding. Residues in the cyan rectangle are in the formation of inter-chain disulfide bond. Residues with the hollow blue triangle are O-linked glycans sites in post-translation. Residues in yellow-green rectangle are hydroxylation sites with GXPG motif. NCBI accession numbers of C1qAs are listed as follows: goose: KP238277; duck: 514725938; bird (zebra finch): 449487169; chicken: 118101238; lizard: XP_003230642.1; mouse: 408359988; human: 399138.
Fig 8Amino acid alignment of complement C1q subcomponent subunit C (C1qC).
Amino acid alignment of C1qC shows the signal peptide, collagen like domain and C1q domain are respectively indicated with a bottle green arrow, orange arrow and blue arrow. Blue Triangle indicates the key residues for CRP interaction. Purple triangle indicates the key residues for IgG interaction. Magenta triangle indicates the sites for HTLVI gp21 peptide binding. Residues in the cyan rectangle are in the formation of inter-chain disulfide bond. Residues in yellow-green rectangle are hydroxylation sites. NCBI accession numbers of C1qCs are listed as follows: goose: KP238279; duck: 514725934; chicken: 50759463; bird (zebra finch):449487244; alligator: 557280504; mouse: 113680120; human: 56786155;
Fig 9Amino acid alignment of suppressor of cytokine signaling 1 (SOCS1).
Amino acid alignment of SOCS1 shows the SH2 domain and SOCS box are respectively indicated by orange arrow and pink arrow. An extended SH2 subdomain is marked with dark green line. Kinase inhibitory region (KIR) is masked with cyan box. The elongin BC complex binding domain, which is also known as BC-box is masked with a yellow box. Suppressor of cytokine signaling region is marked with dark-green double-headed arrow. Functional sites are marked with blue triangles. F51 F54, D59, Y60, I63 and L70 are important for JAK signal transduction suppression and the binding to JH1. R100 is important for LIF signal transduction suppression, the binding to KIT and IL-6 signal transduction suppression. 170L is important for the interaction with elongin BC complex, when it associated with F-179. 174C is also important for the interaction with elongin BC complex, only when it associated with P-175. NCBI accession numbers of SOCS1s are listed as follows: goose: KP238278; duck: 514780149; chicken: 212549671; bird (zebra finch): 224070031; lizard: 637378617; mouse: 409971432; human: 4507233;
Fig 10Amino acid alignment of suppressor of cytokine signaling 3 (SOCS3).
Amino acid alignment of SOCS3 shows the SH2_SOCS3 domain and SOCS_SOCS3 box are respectively indicated by orange arrow and pink arrow. An extended SH2 subdomain is marked with dark green line. Kinase inhibitory region (KIR) is masked with cyan box. Functional sites are marked with blue triangles. L22, F25, E30, Y31, V34, L41, G45 and R71 have an effect on EPO/LIF-induced signaling suppression. L58, L93 and R94 have an effect on the binding to Y429/Y431 phosphorylated EPOR. NCBI accession numbers of SOCS3s are listed as follows: goose: KP238281; duck: 514711433; chicken: 45382967; bird (zebra finch): 224074414; lizard: 637266413; mouse: 6671758; human: 49168482;
Fig 11STRING analysis of immune relevant genes from the goose peripheral blood lymphocytes transcriptome.
The network nodes represent the proteins encoded by the DE genes. Seven different colored lines link a number of nodes and represent seven types of evidence used in predicting the associations. A red line indicates the presence of fusion evidence; a green line represents neighborhood evidence; a blue line represents co-occurrence evidence; a purple line represents experimental evidence; a yellow line represents text-mining evidence; a light blue line represents database evidence, and a black line represents co-expression evidence.